Search

everythinglearnresearchcommunity

for

Search:↓

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Two finasteride tablet types are equally effective and can be swapped.

The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Minoxidil controls blood pressure effectively, but may cause side effects like hypertrichosis.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

Sodium selenate was found to be safe and possibly slows Alzheimer's progression, but more research is needed.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Isotretinoin is a preferred treatment for severe acne, often leading to long-term improvement, but requires careful monitoring due to potential side effects.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

Hormonal therapies are safe and effective for treating adult women's acne.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Topical finasteride helps regrow hair and reduce hair loss in men and women.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Severe acne in a young girl may indicate underlying hormonal issues.

Keratinocytes and adipose-derived stem cells can effectively heal difficult skin wounds.

Gene therapy in mice increased lifespan and improved health without causing cancer.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.